Effect of Follitropin Alpha on Matrix Metalloproteinase-7 Expression in Uterus in Rats

Öz

Follitropin alfa is a type of follicle-stimulating hormone belonging to the hormone family registered as gonadotropins and is used in assisted reproductive technology. In our study, we aimed to demonstrate the expression of Matrix Metalloproteinase-7 in the uterine tissue of animals given Follitropin alfa. In the study, 16 adult female Wistar albino rats with an average weight of 200-220 grams, 8-10 weeks old, were recorded. Follitropin alfa (4IU) filling was administered in a manner that divided the diestrus phase into three segments. Uterine tissues were taken at the end of 21 days. Tissue samples were fixed in 10% buffered neutral formalin solution. Periodic Acid-Schiff and Hematoxylin-eosin staining methods were used for general morphology in tissue uterine samples from which 3 µm sections were taken, and immunofluorescence methods can be used to determine Matrix Metalloproteinase-7 localization. The obtained tissues were compared and evaluated semi-quantitatively by taking photographs in appropriate areas. Morphological comparison between control and experimental groups revealed a marked expansion in the uterine lumen across control categories, along with increased epithelial cell diversity and enhanced delineation of epithelial cell borders. Significant differences in Matrix Metalloproteinase-7 expression were observed between groups. In conclusion, follitropin alfa alters the hormonal milieu of uterine tissue, leading to matrix-related structural changes.

Anahtar Kelimeler

• Follitropin alfa
• matrix metalloproteinase-7
• uterus

Ratlarda Uterusta Follitropin Alfanın Matriks Metalloproteinaz-7 Ekspresyonuna Etkisi

Öz

Follitropin alfa, gonadotropinler olarak tanımlanan hormon ailesine ait bir çeşit folikül uyarıcı hormondur ve yardımla üreme teknolojisinde kullanılmaktadır. Çalışmamızda, Follitropin alfa verilmiş hayvanların uterus dokusu üzerinde, Matrix Metalloproteinaz-7 ekspresyonunun gösterilmesi amaçlanmıştır. Çalışmamızda, vücut ağırlıkları ortalama 200-220 gram ağırlığında 8-10 haftalık Wistar albino cinsi 16 adet erişkin dişi rat kullanıldı. Diöstrus dönemini 3’e bölecek şekilde Follitropin alfa (4 IU) enjeksiyonu yapıldı. 21 günün sonunda uterus dokuları alındı. Dokudan alınan örnekler %10 tamponlanmış nötral formalin çözeltisinde tespit edildi. 3 µm kalınlığında kesitler alınan doku uterus örneklerine genel morfoloji için Periyodik asit–Schiff ve Hematoksilen-eozin boyama yöntemleri, Matriks Metalloproteinaz-7 lokalizasyonun belirlenebilmesi için immünfloresan yöntemler uygulandı. Elde edilen dokular karşılaştırılarak değerlendirildi ve uygun alanlardan fotoğraflar çekilerek semikantitatif olarak değerlendirdi. Kontrol ve deney grupları morfolojik olarak karşılıklı değerlendirildiğinde, deneysel grupta uterus lümeninin kontrol grubuna oranla çok fazla genişlediği, epitel tabakasında yer alan hücrelerin çekirdek sayılarında artışla beraber epitel tabasının da hücre sınırlarında artış meydana geldiği gözlendi. Matrix Metalloproteinaz-7 ekspresyonunda ise gruplar arası yine anlamlı farklılıklar izlendi. Sonuç olarak Follitropin alfa’nın uterus dokusu üzerinde hormonal düzenlenim açısından farklılıklara ve matriks bozulması gibi değişikliklere sebep olabileceği düşünülmektedir.

Anahtar Kelimeler

• Follitropin alfa
• matrix metalloproteinaz-7
• uterus

Kaynakça

1. Olivennes F, Trew G, Borini A et al. Randomized, controlled, openlabel, non inferiority study of the consort algorithm for individualized dosing of follitropin alfa. Reprod Biomed Online. 2015;30(3):248-257. doi: 10.1016/j.rbmo.2014.11.013.
2. Saroj K Pradhan, Yiming Li, Andreas R Gantenbein et al. A Potential Jing Fang Decoction for Headache Disorders? Medicines (Basel). 2022;9(3):22. doi:10.3390/medicines9030022.
3. Jiang J, Dong R, Du M et al. Serum matrix metalloproteinase-7 for discriminating biliary atresia: a diagnostic accuracy and validation study. J Transl Med. 2024;22(1):636. doi:10.1186/s12967-024-05442-x.
4. Yin T, Chen S, Zhou R et al. Relationships of serum MMP-7 and clinical characteristics in choledochal cyst children. BMC Surg. 2024;24(1):195. doi:10.1186/s12893-024-02488-y.
5. Lin C, He H, Cui N, Ren Z, Zhu M, Khalil RA. Decreaseduterinevascularizationanduterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy. Am J Physiol Heart Circ Physiol. 2020;318(1):H165-H180. doi:10.1152/ajpheart.00602.2019.
6. Amir M, Romano S, Goldman S, Shalev E. Plexin-B1, glycodelin and MMP7 expression in the human fallopian tube and in the endometrium. Reprod Biol Endocrinol. 2009;7(1):152.doi:10.1186/1477-7827-7-152.
7. Lass A, McVeigh E. Routine use of r-hFSH follitropin alfa filled-by-mass for follicular development for IVF: a large multicentre observational study in the UK. Reproduct Biomed Online. 2004;9(6):604-610. doi:10.1016/S1472-6483(10)61768-3
8. Hamutoğlu R, Bulut HE, Kaloğlu C, et al. The regulation of trophoblast invasion and decidual reaction by matrix metalloproteinase‐2, metalloproteinase‐7, and metalloproteinase‐9 expressions in the rat endometrium. Reproductive Medicine and Biology. 2020:19(4);385-397. doi:10.1002/rmb2.12342.

9. Kaloğlu C, Bulut HE, Hamutoğlu R et al. Wingless ligands and beta-catenin expression in the rat endometrium: The role of Wnt 3 and Wnt 7a/beta-cateninpath wayat the embryo-uterine interface. Mol Reprod Dev. 2020;87(11):1159-1172. doi:10.1002/mrd.23423.
10. Luo J, Wang W, Sun S. Research advancesin reproduction for dairy goats. Asian-Australas J Anim Sci. 2019;32:1284-1295. doi:10.5713/ajas.19.0486
11. Marco HG, Glendinning S, Ventura T, et al. The gonadotropin-releasing hormone (GnRH) super family across Pancrustacea/Tetraconata: A role in metabolism? Mol Cell Endocrinol. 2024;590:112238. doi: 10.1016/j.mce.2024.112238.
12. Goffin F, Munaut C, Frankenne F, et al. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol Reprod. 2003;69(3):976-984. doi:10.1095/biolreprod.103.015933.
13. Brenner RM and Slayden OV. Molecular and functional aspects of menstruation in the macaque. Rev Endocr Metab Disord. 2012;13:309-318 doi:10.1007/s11154-012-9225-5.
14. Foer D, Buchheit KM, Gargiulo AR, Lynch DM, Castells M, Wickner PG. Progestogen Hypersensitivity in 24 Cases: Diagnosis, Management, and Proposed Renaming and Classification. J Allergy Clin Immunol Pract. 2016;4(4):723-729. doi:10.1016/j.jaip.2023.07.050.
15. Aharon D, Lederman M, Ghofranian A, et al. In vitro fertilization and early pregnancy outcomes after coronavirus disease 2019 (COVID-19) vaccination. Obstet Gyneco .l 2022;139:490-497. doi:10.1097/AOG.0000000000004713.
16. Guo F, Si C, Zhou M, Wang J, Zhang D, Leung PCK. Decreased PECAM1-mediated TGF-beta1expression in the mid-secretory endometrium in women with recurrent implantation failure. Hum Reprod. 2018; 33:832-843. doi:10.1093/humrep/dey022.
17. Barakhoeva Z, Vovk L, Fetisova Y, et al. A multicenter, randomized, phase III study comparing the efficacy and safety of follitropin alpha biosimilar and the original follitropin alpha. Eur J Obstet Gynecol Reprod Biol. 2019;241:6-12. doi:10.1016/j.ejogrb.2019.07.032.
18. Humaidan P, Chin W, D RogoffD, et al. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. Hum Reprod. 2017;32(3):544-555. doi:10.1093/humrep/dew360.
19. Lispi M, Humaidan P, Bousfield GR, D’Hooghe T, Alfredo Ulloa-Aguirre A. Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy? Int J Mol Sci. 2023;19:24(10):9020. doi:10.3390/ijms24109020.